Literature DB >> 15537700

In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model.

Christopher Faber1, Roel J W Hoogendoorn, Hein P Stallmann, D M Lyaruu, Arie van Nieuw Amerongen, Paul I J M Wuisman.   

Abstract

OBJECTIVES: The continued rise in drug-resistant pathogens has led to global research efforts into new antimicrobial agents. A promising class of new agents are the antimicrobial peptides. The aim of the study was to investigate the efficacy of the antimicrobial peptide Dhvar-5 in a prophylactic, methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis model.
METHODS: Dhvar-5 (12 mg or 24 mg/rabbit) was incorporated into polymethyl methacrylate (PMMA) beads as a local drug delivery system. For comparison, plain beads (control) and beads containing gentamicin as a sulphate (10 mg or 24 mg per rabbit) were also prepared. The beads were inserted into the inoculated femoral cavity of 36 rabbits, and 1 week later they were killed. The presence and severity of MRSA osteomyelitis was assessed by culture and histology.
RESULTS: Both the 24 mg Dhvar-5 beads and the 24 mg gentamicin sulphate beads significantly reduced the bacterial load of the inoculated femora compared with the control chain. Although a 24 mg Dhvar-5 dose inhibited MRSA growth, it did not completely sterilize the femora. Sterilization occurred only in some of the gentamicin-treated specimens.
CONCLUSION: We conclude that both the gentamicin beads and the Dhvar-5 beads were only partially effective at preventing MRSA infection in this model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537700     DOI: 10.1093/jac/dkh441

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Testing the efficacy of antimicrobial peptides in the topical treatment of induced osteomyelitis in rats.

Authors:  Pavel Melicherčík; Václav Čeřovský; Ondřej Nešuta; David Jahoda; Ivan Landor; Rastislav Ballay; Petr Fulín
Journal:  Folia Microbiol (Praha)       Date:  2017-08-02       Impact factor: 2.099

2.  Antimicrobial peptide in polymethylmethacrylate bone cement as a prophylaxis of infectious complications in orthopedics-an experiment in a murine model.

Authors:  Pavel Melicherčík; Karel Kotaška; David Jahoda; Ivan Landor; Václav Čeřovský
Journal:  Folia Microbiol (Praha)       Date:  2022-05-25       Impact factor: 2.629

Review 3.  Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens.

Authors:  Mi Nguyen-Tra Le; Miki Kawada-Matsuo; Hitoshi Komatsuzawa
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

4.  A novel canine model of acute pyogenic spondylodiscitis.

Authors:  Wei-Hua Chen; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Neurosurg Rev       Date:  2009-07-15       Impact factor: 3.042

5.  Antimicrobial Peptides for Topical Treatment of Osteomyelitis and Implant-Related Infections: Study in the Spongy Bone.

Authors:  Pavel Melicherčík; Ondřej Nešuta; Václav Čeřovský
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-16

6.  In Vitro Evaluation of Five Antimicrobial Peptides against the Plant Pathogen Erwinia amylovora.

Authors:  Rafael J Mendes; Laura Regalado; João P Luz; Natália Tassi; Cátia Teixeira; Paula Gomes; Fernando Tavares; Conceição Santos
Journal:  Biomolecules       Date:  2021-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.